Stephen D. Barnhill, M.D., Chairman and CEO of Health Discovery Corporation, to Present "The Biomarker Gold Rush is On!" at the Third Annual Collaborations & Licensing in the Pharma & Biotech Industries Conference in London, England

Market Wire, April, 2005

Health Discovery Corporation (OTC BB: HDVY) today announced that Dr. Stephen D. Barnhill, Chairman and CEO, will present "The Biomarker Gold Rush is On!" at the Third Annual Collaborations & Licensing in the Pharma & Biotech Industries Conference in London, England, on June 30, 2005.

Stephen D. Barnhill, M.D., Chairman and CEO of Health Discovery Corporation, commented, "I am honored to be on the faculty of this very prestigious meeting focusing on the increasing role licensing is playing in the business model of pharmaceutical and biotechnology companies." Dr. Barnhill continued, "I look forward to introducing valuable licensing opportunities for Health Discovery Corporation's recent patent-protected biomarker discoveries and discovery tools to this world renowned group of corporate and academic leaders."

More information on the Third Annual Collaborations & Licensing in the Pharma and Biotech industries Conference held on June 20-30, 2005, in London, England, can be found at http://www.smi-online.co.uk/events/overview.asp?is=4&ref=2111

Health Discovery Corporation is a systems biology-oriented biomarker and pathway discovery company, which provides all aspects of First-Phase Biomarker Discovery(SM). The Company was established to provide pharmaceutical and diagnostic companies worldwide with newly discovered biomarkers used to create more accurate diagnostic tests, novel drug targets for more personalized medicines and new methods for detecting patients "at-risk" for toxicity-related events, thereby providing safer medications. Founded in September 2003, the Company is headquartered in Savannah, GA.

This news release contains "forward-looking statements" within the meaning of Section 27A of the Securities Acts of 1933 and Section 21E of the Securities Exchange Act of 1934. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove correct.

Contact: For more information contact: Stephen D. Barnhill, M.D. 1-800-965-3198 Email: barnhillmd@sprynet.com http://www.healthdiscoverycorp.com